Value Sense
MDT
Medtronic plc (MDT)
Last Price$94.32.5%
Market Cap$120.9B
Intrinsic value score
6/10
Good
Intrinsic value
$114.6
DCF value - $89.1 Relative value - $140.2
Undervalued
21.5%
LTM P/E
28.4x
Peer set median 39.4x
Discount rate
7.4%
MDT
is 21.5% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

MDT Intrinsic value

Key Highlights:
Relative Value vs Current Share Price
As of Mar 03, 2025 MDT Relative Value is $140.1, which is undervalued by 48.6%, compared to current share price of $94.3.
DCF Value vs Current Share Price
As of Mar 03, 2025 MDT DCF Value is $88.3, which is overvalued by 6.4%, compared to current share price of $94.3.
Methodology
Price per share, $
MDT
Intrinsic value$114.6
Undervalued by21.5%
Current share price
94.3
Relative value
140.1
DCF value
88.3

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Low P/E stocks

Low P/E stocks

Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.

3M Return 7.5%
S&P Outperformance -5.5%
Next 3M Predicted Return 10.2%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%

MDT Historical Intrinsic Value

Crunching data... Almost there!

MDT vs Peer Set: Intrinsic Value Comparison

General

Intrinsic Value

Financials

Company name

Undervaluation/Overvaluation

Revenue growth

EPS growth

Net income margin

Medtronic plc logo
Medtronic plcMDT
21.5%
3.6%
(2.1%)
11.4%
Median Peer Set
5.6%
126.3%
12.7%
Boston Scientific Corporation logo
Boston Scientific CorporationBSX
(67.4%)
17.6%
16.7%
11.1%
Insulet Corporation logo
Insulet CorporationPODD
(50.7%)
30.0%
4,364.6%
12.2%
DexCom, Inc. logo
DexCom, Inc.DXCM
(49.8%)
11.3%
(1.4%)
14.3%
Edwards Lifesciences Corporation logo
Edwards Lifesciences CorporationEW
(24.2%)
(9.4%)
202.2%
76.7%
Stryker Corporation logo
Stryker CorporationSYK
(22.7%)
10.2%
(5.8%)
13.2%
STERIS plc logo
STERIS plcSTE
(10.4%)
3.6%
257.9%
7.4%
Align Technology, Inc. logo
Align Technology, Inc.ALGN
8.5%
3.4%
26.0%
11.5%
Abbott Laboratories logo
Abbott LaboratoriesABT
24.5%
4.6%
134.5%
31.9%
Zimmer Biomet Holdings, Inc. logo
Zimmer Biomet Holdings, Inc.ZBH
72.0%
6.5%
253.2%
13.8%
Koninklijke Philips N.V. logo
Koninklijke Philips N.V.PHG
146.8%
(0.8%)
118.1%
(3.9%)

Explore more intrinsic value tools hub for MDT

Peter Lynch Fair Value
Intrinsic Value
Earnings Power Value
Ben Graham Fair Value
Earnings growth model
DCF value calculator
Discount rate
Peter Lynch charts
Reverse DCF
Relative Value

FAQ

What is Medtronic plc intrinsic value?

As of Mar 03, 2025, Medtronic plc Intrinsic Value is $114.6. This suggests it may be undervalued by 21.5% compared to its current price of around $94.3.

What is Medtronic plc DCF (discounted cash flow) valuation?

As of Mar 03, 2025, Medtronic plc's Discounted Cash Flow (DCF) valuation estimates its share price at $88.3. This suggests it may be overvalued by 6.4% to its current price of around $94.3, using a discount rate of 7.4% and terminal growth rate of 3.0%.

Is Medtronic plc overvalued or undervalued?

Medtronic plc is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $114.6, compared to a market price of around $94.3. This suggests a potential undervaluation of 21.5%.